Prophylactic and therapeutic uses of FGF-20 in radiation protection

Details for Australian Patent Application No. 2005323489 (hide)

Owner CuraGen Corporation

Inventors Alvarez, Enrique; Hahne, William; Narayanan, Bisni; MaClachlan, Timothy K.

Agent Cullen & Co

Pub. Number AU-A-2005323489

PCT Pub. Number WO2006/073417

Priority 10/980,459 03.11.04 US; 60/613,013 22.09.04 US; 10/842,179 10.05.04 US; 10/842,206 10.05.04 US

Filing date 29 March 2005

Wipo publication date 13 July 2006

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2006/073417 Priority application(s): WO2006/073417

4 January 2007 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name CuraGen Corporation, Application No. 2005323489, under INID (72) correct the name of co-inventor to read MacLachlan, Timothy K

19 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323492-Fugitive viscosity and stability modifiers for carbon nanotube compositions

2005323472-Vaccine conjugates comprising a monoclonal antibody binding to human dendritic cells and beta human chorionic gonadotropin